Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study
Senan, Suresh, Okamoto, Isamu, Lee, Gyeong-won, Chen, Yuanbin, Niho, Seiji, Mak, Gabriel, Yao, Wenliang, Shire, Norah, Jiang, Haiyi, Cho, Byoung ChulLanguage:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2019.12.006
Date:
December, 2019
File:
PDF, 201 KB
english, 2019